BP000151-CYT-602: Recombinant Human IL-28A
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000152-CYT-117: Recombinant Human IL-29, HEK
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.5-5 ug/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000152-CYT-603: Recombinant Human IL-29
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE and RP-HPLC.BP000162-CYT-641: Recombinant Mouse Interleukin-17E (IL17E) Protein
Source: E. coli-derived.
The activity is determined by the dose-dependent production of IL-8 by human PBMCs and is 322-488 ug/ml.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000263-CHM-238: Recombinant Human Eotaxin-2 (CCL24)
Source: E. coli-derived.
The activity is determined by the chemoattract of human PBE (peripheral blood eosinophils) at a concentration between 50-100 ug/ml corresponding to a Specific Activity of 10,000-20,000 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000263-CHM-282: Recombinant Rat Eotaxin-2 (CCL24)
Source: E. coli-derived.
Determined by its ability to chemoattract murine lymphocytes using a concentration range of 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000263-CHM-368: Recombinant Mouse Eotaxin-2 (CCL24)
Source: E. coli-derived.
Determined by its ability to chemoattract murine lymphocytes using a concentration range of 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000264-CHM-362: Recombinant Human C-C Motif Chemokine 26 (CCL26) Protein
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.BP000265-CHM-256: Recombinant Human Eotaxin (CCL11)
Source: E. coli-derived.
The activity is determined by the chemoattract of human PBE (peripheral blood eosinophils) at a concentration between 0.1-10 ug/ml corresponding to a Specific Activity of 10,000-10,000,000 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000265-CHM-260: Recombinant Rat Eotaxin (CCL11)
Source: E. coli-derived.
Fully biologically active. Determined by its ability to chemoattract purified blood eosinophils using a concentration range of 0.1-1.0 ug/ml, corresponding to a Specific Activity of 10-100 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.